ARTICLE | Clinical News
Progen preclinical data
October 29, 2007 7:00 AM UTC
In animal models of melanoma and colorectal cancer, PGL's PG500 series of compounds decreased or prevented human endothelial cell proliferation in response to vascular endothelial growth factor (VEGF...